Flerie
Flerie AB (publ) is a venture capital firm specializing in early-stage investments. The firm seeks to invest in life science, biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, Nordic, United States and Israel. Flerie AB (publ) was founded in 2011 and is based in Stockholm… Read more
Market Cap & Net Worth: Flerie (FLERIE)
Flerie (ST:FLERIE) has a market capitalization of $242.35 Million (Skr2.72 Billion) as of March 19, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #21556 globally and #243 in its home market, demonstrating a -2.77% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Flerie's stock price Skr35.10 by its total outstanding shares 77455962 (77.46 Million).
Flerie Market Cap History: 2024 to 2026
Flerie's market capitalization history from 2024 to 2026. Data shows change from $324.17 Million to $242.35 Million (-21.47% CAGR).
Flerie Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Flerie's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
29.38x
Flerie's market cap is 29.38 times its annual revenue
1740.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $324.17 Million | $100.00K | -$228.00 Million | 3241.68x | N/A |
| 2025 | $258.57 Million | $8.80 Million | -$756.90 Million | 29.38x | N/A |
Competitor Companies of FLERIE by Market Capitalization
Companies near Flerie in the global market cap rankings as of March 19, 2026.
Key companies related to Flerie by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Flerie Historical Marketcap From 2024 to 2026
Between 2024 and today, Flerie's market cap moved from $324.17 Million to $ 242.35 Million, with a yearly change of -21.47%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr242.35 Million | -6.28% |
| 2025 | Skr258.57 Million | -20.23% |
| 2024 | Skr324.17 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Flerie was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $242.35 Million USD |
| MoneyControl | $242.35 Million USD |
| MarketWatch | $242.35 Million USD |
| marketcap.company | $242.35 Million USD |
| Reuters | $242.35 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.